FindTrial
Sign In

Analysis of non-steroidal anti-inflammatory drugs use after elbow trauma surgery with heterotopic ossification prevention and fracture nonunion risk: a retrospective propensity score-matched cohort study

Analysis of non-steroidal anti-inflammatory drugs use after elbow trauma surgery with heterotopic ossification prevention and fracture nonunion risk

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062155
Enrollment
Unknown
Registered
2022-07-25
Start date
2022-10-12
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elbow Heterotopic Ossification

Interventions

1:nonuser
2:NSAIDs user

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who received surgery for elbow trauma from January 1, 2019, to June 30, 2021, were included.

Exclusion criteria

Exclusion criteria: Those were not an adult when injured, old fractures, associated with center nervous system, spine cord or burn injury, and destructive injury in the ipsilateral upper limb were excluded. Patients who met the inclusion and exclusion criteria while were refusal or loss to follow up were further excluded.

Design outcomes

Primary

MeasureTime frame
Heterotopic ossification;—

Secondary

MeasureTime frame
fracture nonunion;—

Countries

China

Contacts

Public ContactFan Cunyi

Shanghai Sixth People's Hospital

cyfan@sjtu.edu.cn+86 18930175149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026